undamentalytics Newsletter

Establishment Labs Holdings vs Treace Medical Concepts

Establishment Labs Holdings and Treace Medical Concepts are similar in size: $211m and $213m of revenue in their latest fiscal years. Establishment Labs Holdings grew faster (27.1% against 1.6%). Establishment Labs Holdings kept more of each dollar of sales as profit: a net margin of -24.2% against -27.7%. Treace Medical Concepts carries less debt relative to equity (68.7% against 1051.2%).

Latest fiscal yearEstablishment Labs HoldingsESTA, 2025Treace Medical ConceptsTMCI, 2025
Revenue $211m $213m
Revenue growth 27.1% 1.6%
Net income −$51.1m −$59.0m
Operating margin -18.5% -25.5%
Net margin -24.2% -27.7%
Return on equity -133.3% -58.9%
Free cash flow −$56.9m −$29.5m
Cash $75.6m $10.7m
Total debt $248m $60.0m
Debt to equity 1051.2% 68.7%
Dividend per share — —
Dividend yield — —
Share buybacks — —
Employees 1,004 450
Market value $1.82bn $278m
Price vs our value range — —
Moat score 31 (Weak) 30 (Weak)
Insider trades, 12 months 0 buys, 30 sales 14 buys, 0 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.